Preferable II
Personalised Exercise-Oncology for improvement of supportive care: a super umbrella trial to demonstrate the (cost)effectiveness of live-remote exercise in cancer survivors
Latest news
22/04/2025 - Event
6th consortium meeting in Lisbon
In our 6th consortium meeting we discussed our substudies LION-ELSI and LION-COM: how can we better understand views and attitudes of cancer survivors towards online supervised exercise and how can we communicate best to these people?
04/02/2025 - Event
A Powerful Patient Perspective
On World Cancer Day, former EFFECT trial participant Ineke shared a moving story about how exercise has transformed her life.
Collaboration
PREFERABLE II consists of an international consortium of twelve academic partners, one cutting edge game development and software engineering SME, an academic clinical research organisation and one European patient organisation (European Cancer Patient Coalition). The partners are from seven countries: the Netherlands, Germany, Sweden, Portugal, Spain, UK and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.
Our partners
